Mark R Green - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mark R Green

Showing results (51-60 of 64) with videos related to

Pageof 7

Sort By:

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group BEverett E Vokes, James E Herndon, Michael J Kelley, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010

Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633Stephen L Graziano, Lin Gu, Xiaofei Wang, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009

Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904Jeffrey A Bogart, Lydia Hodgson, Stephen L Seagren, et al.

Cancer Chemotherapy and Pharmacology|February 25, 2014

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTereHeloisa P Soares, Soley Bayraktar, Marcelo Blaya, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003

Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761Robin T Vollmer, James E Herndon, Jonathan D'Cunha, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancerThomas E Stinchcombe, Lydia Hodgson, James E Herndon, et al.

Cancer|May 7, 2003

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group BWallace Akerley, James E Herndon, Merrill J Egorin, et al.

Journal of the National Cancer Institute|February 21, 2002

Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group BA William Blackstock, James E Herndon, Electra D Paskett, et al.

Lung Cancer (Amsterdam, Netherlands)|April 15, 2005

Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trialJonathan D'Cunha, James E Herndon, Debra L Herzan, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730)Rogerio C Lilenbaum, James E Herndon, Marcy A List, et al.

Pageof 7

Search research articles

Showing results (51-60 of 64) with videos related to

Sort By:

Pageof 7

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2007

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2010

Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633Stephen L Graziano, Lin Gu, Xiaofei Wang, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009

Cancer Chemotherapy and Pharmacology|February 25, 2014

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTereHeloisa P Soares, Soley Bayraktar, Marcelo Blaya, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009

Cancer|May 7, 2003

Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group BWallace Akerley, James E Herndon, Merrill J Egorin, et al.

Journal of the National Cancer Institute|February 21, 2002

Lung Cancer (Amsterdam, Netherlands)|April 15, 2005

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730)Rogerio C Lilenbaum, James E Herndon, Marcy A List, et al.

Pageof 7